Vitestro Achieves CE Marking for Autonomous Blood Drawing Device
Utrecht, The Netherlands, August 28, 2024 – Vitestro, a pioneer in the field of medical robotics, is proud to announce that its innovative automated blood drawing device has received CE marking. This marks a significant milestone for the company, acknowledging that the device meets the requirements of the European Medical Device Regulation (MDR) and is now approved for commercial use across the European Union.
Ander nieuws
Vitestro haalt €60 miljoen op in Series B financieringsronde voor doorontwikkeling autonome bloedafname en commerciële opschaling
InterVest, Labcorp Venture Fund, Mayo Clinic, MGFO, PGGM, Puma Venture Capital, ROM Utrecht, en Sutter Health investeren samen met bestaande investeerders Invest-NL, European Innovation Council Fund (EIC Fund), NYBC Ventures, en Sonder Capital.
Vitestro launches new website and first public video of Aletta® Autonomous Robotic Phlebotomy Device™
Vitestro, a pioneer in medical robotics advancing automated diagnostic blood collection, today announced the launch of its new corporate website and the release of its first publicly available video.